<p>Geode Capital Management LLC 在最近向证券交易委员会的披露中表示，在第二季度其在 Regencell Bioscience Holdings Limited (NASDAQ:RGC - 免费报告) 的持股增加了 5,637.5%。该公司在此期间购买了额外的 384,250 股后，持有该公司 391,066 股股票。Geode Capital Management LLC 在 Regencell Bioscience 的持股在最近的报告期末价值为 6,664,000 美元。</p>
<p>获取 <strong>Regencell Bioscience</strong> 的提醒：</p>
<ul>
<li>按表现排名的最佳股票选择 AI</li>
</ul>
<p>另外，Greenfield Savings Bank 在第二季度收购了 Regencell Bioscience 的新股份，价值 187,000 美元。对冲基金和其他机构投资者持有该公司 0.13% 的股票。</p>
<h2>华尔街分析师预测增长</h2>
<p>另外，Weiss Ratings 在周一的一份研究报告中重申了对 Regencell Bioscience 股票的 &#34;卖出 (e+)&#34; 评级。根据 MarketBeat 的数据，一位股票研究分析师对该股票给予了卖出评级，该公司的共识评级为 &#34;卖出&#34;。</p>
<p><strong>阅读我们关于 Regencell Bioscience 的最新股票报告</strong></p>
<h2>Regencell Bioscience 股票上涨 1.5%</h2>
<p>RGC 股票在周五开盘价为 16.24 美元。该公司的 50 日移动平均线为 15.00 美元。Regencell Bioscience Holdings Limited 的一年最低价为 0.09 美元，一年最高价为 83.60 美元。</p>
<h2>Regencell Bioscience 简介</h2>
<p>(免费报告)</p>
<p>Regencell Bioscience Holdings Limited 运营一家传统中医 (TCM) 生物科技公司。它专注于中医的研究、开发和商业化，旨在治疗神经认知障碍和退化，主要是注意力缺陷多动症和自闭症谱系障碍。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 Regencell Bioscience</li>
<li>今日最大股票亏损者 - 最大百分比下跌者</li>
<li>Rocket Lab 的大反弹？分析师建议此跌幅是个机会</li>
<li>消费者价格指数测量什么？</li>
<li>Meta 的 AI 时刻？新 SAM 3 模型让华尔街转向看涨</li>
<li>上海证券交易所综合指数是什么？</li>
<li>Snowflake 股票：聪明投资者现在正在购买的跌幅</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UkdD?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UkdD"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Regencell Bioscience 吗？</h2>
<p>在考虑 Regencell Bioscience 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Regencell Bioscience 并不在名单上。</p>
<p>虽然 Regencell Bioscience 目前在分析师中被评为卖出，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

脑再生科技

<p>Geode Capital Management LLC 在第二季度将其在脑再生科技的持股增加了 5,637.5%，目前市值为 666 万美元。尽管如此，分析师对该股票维持 “卖出” 评级。脑再生科技专注于针对神经认知障碍的传统中医。该股票开盘价为 16.24 美元，52 周价格区间为 0.09 至 83.60 美元。机构投资者持有该股票的 0.13%</p>

<p>Geode Capital Management LLC increased its position in shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC - Free Report) by 5,637.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 391,066 shares of the company's stock after purchasing an additional 384,250 shares during the period. Geode Capital Management LLC's holdings in Regencell Bioscience were worth $6,664,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Geode Capital Management LLC 在最近向证券交易委员会的披露中表示，在第二季度其在 Regencell Bioscience Holdings Limited (NASDAQ:RGC - 免费报告) 的持股增加了 5,637.5%。该公司在此期间购买了额外的 384,250 股后，持有该公司 391,066 股股票。Geode Capital Management LLC 在 Regencell Bioscience 的持股在最近的报告期末价值为 6,664,000 美元。</p>
</div><p>Get <strong>Regencell Bioscience</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Regencell Bioscience</strong> 的提醒：</p>
</div><ul>
<li>The Best AI for Picking Stocks, Ranked by Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>按表现排名的最佳股票选择 AI</li>
</ul>
</div><p>Separately, Greenfield Savings Bank acquired a new stake in Regencell Bioscience during the second quarter worth $187,000. Hedge funds and other institutional investors own 0.13% of the company's stock.</p>
<div class="lb-trans"><p>另外，Greenfield Savings Bank 在第二季度收购了 Regencell Bioscience 的新股份，价值 187,000 美元。对冲基金和其他机构投资者持有该公司 0.13% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Separately, Weiss Ratings restated a &#34;sell (e+)&#34; rating on shares of Regencell Bioscience in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在周一的一份研究报告中重申了对 Regencell Bioscience 股票的 &#34;卖出 (e+)&#34; 评级。根据 MarketBeat 的数据，一位股票研究分析师对该股票给予了卖出评级，该公司的共识评级为 &#34;卖出&#34;。</p>
</div><p><strong>Read Our Latest Stock Report on Regencell Bioscience</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Regencell Bioscience 的最新股票报告</strong></p>
</div><h2>Regencell Bioscience Trading Up 1.5%</h2>
<div class="lb-trans"><h2>Regencell Bioscience 股票上涨 1.5%</h2>
</div><p>Shares of RGC stock opened at $16.24 on Friday. The company has a fifty day moving average of $15.00. Regencell Bioscience Holdings Limited has a one year low of $0.09 and a one year high of $83.60.</p>
<div class="lb-trans"><p>RGC 股票在周五开盘价为 16.24 美元。该公司的 50 日移动平均线为 15.00 美元。Regencell Bioscience Holdings Limited 的一年最低价为 0.09 美元，一年最高价为 83.60 美元。</p>
</div><h2>Regencell Bioscience Profile</h2>
<div class="lb-trans"><h2>Regencell Bioscience 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.</p>
<div class="lb-trans"><p>Regencell Bioscience Holdings Limited 运营一家传统中医 (TCM) 生物科技公司。它专注于中医的研究、开发和商业化，旨在治疗神经认知障碍和退化，主要是注意力缺陷多动症和自闭症谱系障碍。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Regencell Bioscience</li>
<li>Biggest Stock Losers - Today’s Biggest Percentage Decliners</li>
<li>Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift</li>
<li>What does consumer price index measure?</li>
<li>Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>Snowflake Stock: The Dip That Smart Investors Are Buying Right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Regencell Bioscience</li>
<li>今日最大股票亏损者 - 最大百分比下跌者</li>
<li>Rocket Lab 的大反弹？分析师建议此跌幅是个机会</li>
<li>消费者价格指数测量什么？</li>
<li>Meta 的 AI 时刻？新 SAM 3 模型让华尔街转向看涨</li>
<li>上海证券交易所综合指数是什么？</li>
<li>Snowflake 股票：聪明投资者现在正在购买的跌幅</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UkdD" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=RGC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Regencell Bioscience Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Regencell Bioscience 吗？</h2>
</div><p>Before you consider Regencell Bioscience, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Regencell Bioscience 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Regencell Bioscience 并不在名单上。</p>
</div><p>While Regencell Bioscience currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Regencell Bioscience 目前在分析师中被评为卖出，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Geode Capital Management LLC 持有脑再生科技控股有限公司价值 666 万美元的股份